Status | Study |
RECRUITING |
Study Name: Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio Condition: Bile Duct Cancer Date: 2022-12-09 Interventions: Intravenous infusion |
Recruiting |
Study Name: Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer Condition: Colon Carcinoma Liver and Intrahepatic Bile Duct Carcinoma Date: 2017-04-29 Interventions: Procedure: Biospecimen Collection |
Not yet recruiting |
Study Name: Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma Condition: Bile Duct Cancer Intrahepatic Cholangiocarcinoma Date: 2017-03-13 Interventions: Combination Product: Melphalan/HDS |
Not yet recruiting |
Study Name: Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer Condition: Adenocarcinoma Metastatic Biliary Tract Cancer Adenocarcin Date: 2017-01-23 Interventions: Drug: Arm NaI-IRI + 5-FU + Leucovorin (Arm A) |
Not yet recruiting |
Study Name: Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient Condition: Biliary Obstructive Disease Such as Choledocholithiasis Benign Biliary Stricture Date: 2016-11-01 Interventions: Biological: Pacetin® (cefoxitin) |
Recruiting |
Study Name: Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy Condition: Pancreatic Cancer Bile Duct Cancer Date: 2016-09-07 Interventions: Procedure: PrPD with proximal Roux-en-y gastrojejunal anastomosis |
Withdrawn |
Study Name: Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery Condition: Bile Duct Adenocarcinoma Stage III Intrahepatic Cholangiocarcinoma Date: 2016-07-27 Interventions: Drug: Capecitabine Given PO |
Enrolling by invitation |
Study Name: Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis Condition: Liver Cancer Bile Duct Cancer Date: 2016-07-19 Interventions: Device: 'Intra-luminal radiofrequency ablation (Habib EndoHPB) endobiliary radiofrequency ablation devic |
Withdrawn |
Study Name: Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma Condition: Non-Resectable Cholangiocarcinoma Recurrent Cholangiocarcinoma Date: 2016-07-14 Interventions: Drug: Cisplatin Given IV |
Recruiting |
Study Name: Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy Condition: Gastric Cancer Pancreas Cancer Bile Date: 2016-07-06 Interventions: Behavioral: Early Palliative Care visit |